Literature DB >> 27870730

Cutaneous Sebaceous Lesions in a Patient With MUTYH-Associated Polyposis Mimicking Muir-Torre Syndrome.

Denisa Kacerovska1, Lubomir Drlik, Lenka Slezakova, Michal Michal, Jan Stehlik, Monika Sedivcova, Ladislav Hadravsky, Dmitry V Kazakov.   

Abstract

A 76-year-old white male with a history of adenocarcinoma of the rectosigmoideum and multiple colonic polyps removed at the age of 38 and 39 years by an abdominoperitoneal amputation and total colectomy, respectively, presented with multiple whitish and yellowish papules on the face and a verrucous lesion on the trunk. The lesions were surgically removed during the next 3 years and a total of 13 lesions were investigated histologically. The diagnoses included 11 sebaceous adenomas, 1 low-grade sebaceous carcinoma, and 1 squamous cell carcinoma. In some sebaceous lesions, squamous metaplasia, intratumoral heterogeneity, mucinous changes, and peritumoral lymphocytes as sometimes seen in sebaceous lesions in Muir-Torre syndrome were noted. Mutation analysis of the peripheral blood revealed a germline mutation c.692G>A,p.(Arg231His) in exon 9 and c.1145G>A, p.(Gly382Asp) in exon 13 of the MUTYH gene. A KRAS mutation G12C (c.34G>T, p.Gly12Cys) was detected in 1 sebaceous adenoma and a NRAS mutation Q61K (c.181C>A, p.Gln61Lys) was found in 2 other sebaceous adenomas. No germline mutations in MLH1, MSH2, MSH6 and PMS2 genes, no microsatellite instability, no aberrant methylation of MLH1 promoter, and no somatic mutations in MSH2 and MSH6 were found. An identical MUTYH germline mutation was found in the patient's daughter. Despite striking clinicopathological similarities with Muir-Torre syndrome, the molecular biologic testing confirmed the final diagnosis of MUTYH-associated polyposis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27870730     DOI: 10.1097/DAD.0000000000000649

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  6 in total

1.  [Sebaceous carcinoma in situ in extraocular skin : Case report and discussion of the new entity].

Authors:  Jan Hrudka; Alžběta Bezvodová; Monika Arenbergerová; Eva Sticová; Dave Bandke
Journal:  Hautarzt       Date:  2020-01       Impact factor: 0.751

Review 2.  Sebaceous Carcinoma: A Review of the Scientific Literature.

Authors:  Thomas Knackstedt; Faramarz H Samie
Journal:  Curr Treat Options Oncol       Date:  2017-08

Review 3.  MUTYH-associated tumor syndrome: The other face of MAP.

Authors:  Luigi Magrin; Daniele Fanale; Chiara Brando; Lidia Rita Corsini; Ugo Randazzo; Marianna Di Piazza; Vittorio Gurrera; Erika Pedone; Tancredi Didier Bazan Russo; Salvatore Vieni; Gianni Pantuso; Antonio Russo; Viviana Bazan
Journal:  Oncogene       Date:  2022-04-14       Impact factor: 9.867

4.  Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis.

Authors:  Erin G Sutcliffe; Amanda Bartenbaker Thompson; Amy R Stettner; Megan L Marshall; Maegan E Roberts; Lisa R Susswein; Ying Wang; Rachel T Klein; Kathleen S Hruska; Benjamin D Solomon
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

5.  Familial Associations of Colorectal Cancer with Other Cancers.

Authors:  Hongyao Yu; Akseli Hemminki; Kristina Sundquist; Kari Hemminki
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

6.  Sebaceous carcinoma in situ as a concept and diagnostic entity.

Authors:  Miglena K Komforti; Masoud Asgari; Sheng Chen
Journal:  Dermatol Pract Concept       Date:  2017-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.